Evidence map›Paper›PMID 31890165›Full record

ArticleFood science & nutrition2019

Alpha-linolenic acid given as an anti-inflammatory agent in a mouse model of colonic inflammation.

Juan Wen, Israr Khan, Anping Li, Xinjun Chen, Pingrong Yang, Pingshun Song, Yaping Jing, Junshu Wei, Tuanjie Che, Chunjiang Zhang

Open access · hybridAbstract read
In one paragraph

Article in Food science & nutrition, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Effect ofFrontiers in veterinary science · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Nutritional immunomodulation of Atlantic salmon response toFrontiers in molecular biosciences · 2022
    Article
  16. Anti-inflammatory effect ofResearch in pharmaceutical sciences · 2021
    Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Juan WenSchool of Life Sciences Lanzhou University Lanzhou China.
Israr KhanSchool of Life Sciences Lanzhou University Lanzhou China.ORCID https://orcid.org/0000-0002-6757-0249
Anping LiSchool of Life Sciences Lanzhou University Lanzhou China.
Xinjun ChenLaboratory of Pathogenic Biology and Immunology Hainan Medical University Haikou China.
Pingrong YangSchool of Life Sciences Lanzhou University Lanzhou China.
Pingshun SongSchool of Life Sciences Lanzhou University Lanzhou China.
Yaping JingSchool of Life Sciences Lanzhou University Lanzhou China.
Junshu WeiSchool of Life Sciences Lanzhou University Lanzhou China.
Tuanjie CheGansu Key Laboratory of Functional Genomics and Molecular Diagnosis Lanzhou China.
Chunjiang ZhangSchool of Life Sciences Lanzhou University Lanzhou China.ORCID https://orcid.org/0000-0002-2297-5023
Lanzhou University · CNGuangdong Institute for Drug Control · CNHainan Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study examined the relationship between the high-fat, high-sugar diet (HFHSD) and trinitrobenzene sulfonic acid (TNBS) induced mouse colitis, the therapeutic effect of alpha-linolenic acid (ALA) on mouse colitis, and the relationship between HFHSD and hyperlipidemia. We also examined the possible underlying mechanisms behind their interactions. Female BABL/c mice were fed with HFHSD for the 9 weeks. At the same time, ALA treatment (150 or 300 mg/kg) was administered on a daily basis. At the end of the 9 weeks, experimental colitis was induced by the intra-colonic administration of TNBS. Body weight, spleen weight, disease activity index (DAI), histological changes, T-cell-related cytokine level, and lipid profiles were measured after treatment. TNBS induced severe clinical manifestations of colitis and histological damage. Low-ALA (150 mg/kg) administration profoundly ameliorated TNBS-induced clinical manifestations, body weight loss, spleen weight loss, and histological damage. On the contrary, the high-ALA (300 mg/kg) administration did not ameliorate colitis and even exacerbated the symptoms. HFHSD consumption assisted TNBS in changing IL-12, IFN-γ, IL-2, and IL-17A in the liver. As expected, these changes were recovered through low-ALA. In addition, HFHSD had a significant impact on the total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and triglyceride (TG), which related to the increased risk of hyperlipidemia. In summation, HFHSD exacerbated the TNBS-induced colitis via the Th1/Th17 pathway. The Low-ALA (150 mg/kg) exhibited protective effects against the TNBS-induced colitis via the Th1/Th2/Th17 pathway.

Indexed as

inflammatory bowel diseaseT‐cell‐related cytokinesα‐linolenic acid

Identifiers

PMID31890165
PMCPMC6924294
OpenAlexW2989931517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.